Marco has invested over the years in some 30 innovative start-ups/SMEs. He contributed to the restructuring of the ‘Eporgen Venture group’ as President of the board of liquidators, setting up ‘SalvaEporgen Soc.semplice’ with the shareholders concerned, which acquired the non-performing bank debt and concentrated resources on 3 of the 11 biotech start-ups then operating at the Bioindustry Park in Collaretto Giacosa.Adjunct professor of Business Econ. at the Polytechnic of Turin, Ctu at the Court of Turin, Publicist journalist with several publications and articles.